How to measure substantia nigra hyperechogenicity in Parkinson disease : Detailed guide with video

Journal of Ultrasound in Medicine

Volumn 32, Issue 10, 2013, Pages 1837-1843

  Walter, Uwe ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Methodological standard; Parkinson disease; Parkinsonism; Substantia nigra; Transcranial sonography

Indexed keywords

DIAGNOSIS; GRADING; MEASUREMENT ERRORS; NEURODEGENERATIVE DISEASES; ULTRASONIC EQUIPMENT;

DIAGNOSTIC IMPLICATIONS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; PARKINSON DISEASE; PARKINSONISM; SUBSTANTIA NIGRA; TRANSCRANIAL SONOGRAPHY; ULTRASOUND SYSTEM;

ULTRASONOGRAPHY;

AGED; ALGORITHM; CASE REPORT; COMPUTER ASSISTED DIAGNOSIS; ECHOENCEPHALOGRAPHY; ECHOGRAPHY; FEMALE; HUMAN; IMAGE ENHANCEMENT; MALE; PARKINSON DISEASE; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SUBSTANTIA NIGRA; ARTICLE; METHODOLOGICAL STANDARD; METHODOLOGY; PARKINSONISM; TRANSCRANIAL SONOGRAPHY;

AGED; ALGORITHMS; ECHOENCEPHALOGRAPHY; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; PARKINSON DISEASE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBSTANTIA NIGRA;

METHODOLOGICAL STANDARD; PARKINSON DISEASE; PARKINSONISM; SUBSTANTIA NIGRA; TRANSCRANIAL SONOGRAPHY;

EID: 84885464166     PISSN: 02784297     EISSN: 15509613     Source Type: Journal    
DOI: 10.7863/ultra.32.10.1837     Document Type: Article

References (41)

1. Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners K. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography. Neurology 1995; 45:182-184.
2. Berg D, Godau J, Walter U. Transcranial sonography in movement disorders. Lancet Neurol 2008; 7:1044-1055.
3. Walter U, Dressler D, Probst T, et al. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease. Arch Neurol 2007; 64:1635-1640.
4. Gaenslen A, Unmuth B, Godau J, et al. The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study. Lancet Neurol 2008; 7:417-424.
5. Stockner H, Sojer M, Seppi K, et al. Midbrain sonography in patients with essential tremor. Mov Disord 2007; 22:414-417.
6. Doepp F, Plotkin M, Siegel L, et al. Brain parenchyma sonography and 123I-FP-CIT SPECT in Parkinson's disease and essential tremor. Mov Disord 2008; 23:405-410.
7. Walter U, Behnke S, Eyding J, et al. Transcranial brain parenchyma sonography in movement disorders: state of the art. Ultrasound Med Biol 2007; 33:15-25.
8. Berg D, Becker G, Zeiler B, et al. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 1999; 53:1026-1031.
9. Walter U, Klein C, Hilker R, et al. Brain parenchyma sonography detects preclinical Parkinsonism. Mov Disord 2004; 19:1445-1449.
10. Sommer U, Hummel T, Cormann K, et al. Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT. Mov Disord 2004; 19:1196-1202.
11. Iranzo A, Lomena F, Stockner H, et al. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol2010; 9:1070-1077.
12. Berg D, Seppi K, Behnke S, et al. Enlarged substantia nigra hyper echo-genicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older persons. Arch Neurol 2011; 68:932-937.
13. Skoloudik D, Walter U. Method and validity of transcranial sonography in movement disorders. Int Rev Neurobiol 2010; 90:7-34.
14. van de Loo S, Walter U, Behnke S, et al. Reproducibility and diagnostic accuracy of substantia nigra sonography for the diagnosis of Parkinson's disease. J Neurol Neurosurg Psychiatry 2010; 81:1087-1092.
15. Plate A, Ahmadi SA, Pauly O, Klein T, Navab N, Botzel K. Threedimensional sonographic examination of the midbrain for computeraided diagnosis of movement disorders. Ultrasound Med Biol 2012; 38:2041-2050.
16. Blahuta J, Soukup T, Cermak P, Rozsypal J, Vecerek M. Ultrasound medical image recognition with artificial intelligence for Parkinson's disease classification. In: Biljanovic P, Butkovic Z, Skala K, et al (eds). Proceedings of the 35th International Convention on Information and Communication Technology, Electronics and Microelectronics. Rijeka, Croatia: Croatian Society for Information and Communication Technology, Electronics and Microelectronics; 2012:958-962.
17. Oikawa H, Sasaki M, Tamakawa Y, Ehara S, Tohyama K. The substantia nigra in Parkinson disease: proton density-weighted spin-echo and fast short inversion time inversion-recovery MR findings. AJNR Am J Neuroradiol 2002; 23:1747-1756.
18. Walter U, Dressler D, Wolters A, Probst T, Grossmann A, Benecke R. Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy. Neurology 2004; 63:504-509.
19. Hagenah JM, Konig IR, Becker B, et al. Substantia nigra hyperecho genicity correlates with clinical status and number of Parkin mutated alleles. J Neurol 2007; 254:1407-1413.
20. Kim JY, Kim ST, Jeon SH, Lee WY. Midbrain transcranial sonography in Korean patients with Parkinson's disease. Mov Disord 2007 ;22:1922-1926.
21. Walter U, Dressler D, Wolters A, Wittstock M, Greim B, Benecke R. Sonographic discrimination of dementia with Lewy bodies and Parkinson's disease with dementia. J Neurol 2006; 253:448-454.
22. Budisic M, Trkanjec Z, Bosnjak J, Lovrencic-Huzjan A, Vukovic V, Demarin V. Distinguishing Parkinson's disease and essential tremor with transcranial sonography. Acta Neurol Scand 2009; 119:17-21.
23. Mijajlovic M, Petrovic I, Stojkovic T, Svetel M, Stefanova E, Kostic VS. Transcranial parenchymal sonography in the diagnosis of Parkinson's disease [in Serbian]. Vojnosanit Pregl 2008; 65:601-605.
24. Ressner P, Skoloudik D, Hlustik P, Kanovsky P. Hyperechogenicity of the substantia nigra in Parkinson's disease. J Neuroimaging 2007; 17:164-167.
25. Go CL, Frenzel A, Rosales RL, et al. Assessment of substantia nigra echogenicity in German and Filipino populations using a portable ultrasound system. J Ultrasound Med 2012; 31:191-196.
26. Mijajlovic M, Dragasevic N, Stefanova E, Petrovic I, Svetel M, Kostic VS. Transcranial sonography in spinocerebellar ataxia type 2. J Neurol 2008; 255:1164-1167.
27. Fedotova EIu, Chechetkin AO, Shadrina MI, et al. Transcranial sonography in Parkinson's disease [in Russian]. Zh Nevrol Psikhiatr Im SS Korsakova 2011; 111:49-55.
28. Huang YW, Jeng JS, Tsai CF, Chen LL, Wu RM. Transcranial imaging of substantia nigra hyperechogenicity in a Taiwanese cohort of Parkinson's disease. Mov Disord 2007; 22:550-555.
29. Mehnert S, Reuter I, Schepp K, Maaser P, Stolz E, Kaps M. Transcranial sonography for diagnosis of Parkinson's disease. BMC Neurol 2010; 10:9.
30. Glaser M, Weber U, Hinrichs H, et al. Neuroimaging of midbrain structures with different phased-array ultrasound systems. Klin Neurophysiol 2006; 37:165-168.
31. Walter U, Niehaus L, Probst T, Benecke R, Meyer BU, Dressler D. Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes. Neurology 2003; 60:74-77.
32. Okawa M, Miwa H, Kajimoto Y, et al. Transcranial sonography of the substantia nigra in Japanese patients with Parkinson's disease or atypical parkinsonism: clinical potential and limitations. Intern Med 2007; 46:1527-1531.
33. Ebentheuer J, Canelo M, Trautmann E, Trenkwalder C. Substantia nigra echogenicity in progressive supranuclear palsy. Mov Disord 2010; 25:773-777.
34. Busse K, Heilmann R, Kleinschmidt S, et al. Value of combined midbrain sonography, olfactory and motor function assessment in the differential diagnosis of early Parkinson's disease. J Neurol Neurosurg Psychiatry 2012; 83:441-447.
35. Skoloudik D, Fadrna T, Bartova P, et al. Reproducibility of sonographic measurement of the substantia nigra. Ultrasound Med Biol 2007; 33:1347-1352.
36. Walter U, Hoeppner J, Prudente-Morrissey L, Horowski S, Herpertz SC, Benecke R. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders. Brain 2007; 130:1799-1807.
37. Prestel J, Schweitzer KJ, Hofer A, Gasser T, Berg D. Predictive value of transcranial sonography in the diagnosis of Parkinson's disease. Mov Disord 2006; 21:1763-1765.
38. Luo WF, Zhang YC, Sheng YJ, Fang JC, Liu CF. Transcranial sonography on Parkinson's disease and essential tremor in a Chinese population. Neurol Sci 2012; 33:1005-1009.
39. Vlaar A, Tromp SC, Weber WE, Hustinx RM, Mess WH. The reliability of transcranial duplex scanning in parkinsonian patients: comparison of different observers and ultrasound systems. Ultraschall Med 2011; 32(suppl 1):S83-S88.
40. Vlaar AM, de Nijs T, van Kroonenburgh MJ, et al. The predictive value of transcranial duplex sonography for the clinical diagnosis in undiagnosed parkinsonian syndromes: comparison with SPECT scans. BMC Neurol 2008; 8:42.
41. Berg D. Hyperechogenicity of the substantia nigra: pitfalls in assessment and specificity for Parkinson's disease. J Neural Transm 2011; 118:453-461.